GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (STU:PQX1) » Definitions » Cyclically Adjusted PB Ratio

Biotage AB (STU:PQX1) Cyclically Adjusted PB Ratio : 9.00 (As of May. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Biotage AB Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Biotage AB's current share price is €14.49. Biotage AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1.61. Biotage AB's Cyclically Adjusted PB Ratio for today is 9.00.

The historical rank and industry rank for Biotage AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:PQX1' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.22   Med: 13.35   Max: 26.88
Current: 9.1

During the past years, Biotage AB's highest Cyclically Adjusted PB Ratio was 26.88. The lowest was 5.22. And the median was 13.35.

STU:PQX1's Cyclically Adjusted PB Ratio is ranked worse than
89.08% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs STU:PQX1: 9.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biotage AB's adjusted book value per share data for the three months ended in Mar. 2024 was €4.295. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotage AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biotage AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Cyclically Adjusted PB Ratio Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.41 14.47 23.78 13.33 7.56

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.17 8.58 6.44 7.56 9.74

Competitive Comparison of Biotage AB's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Biotage AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's Cyclically Adjusted PB Ratio falls into.



Biotage AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biotage AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=14.49/1.61
=9.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotage AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotage AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.295/130.9575*130.9575
=4.295

Current CPI (Mar. 2024) = 130.9575.

Biotage AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.791 100.432 1.031
201409 0.809 100.161 1.058
201412 0.848 100.225 1.108
201503 0.887 99.950 1.162
201506 0.826 99.995 1.082
201509 0.846 100.228 1.105
201512 0.913 100.276 1.192
201603 0.939 100.751 1.221
201606 0.845 101.019 1.095
201609 0.871 101.138 1.128
201612 0.896 102.022 1.150
201703 0.966 102.022 1.240
201706 0.865 102.752 1.102
201709 0.922 103.279 1.169
201712 0.947 103.793 1.195
201803 1.003 103.962 1.263
201806 0.950 104.875 1.186
201809 0.998 105.679 1.237
201812 1.048 105.912 1.296
201903 1.209 105.886 1.495
201906 1.128 106.742 1.384
201909 1.244 107.214 1.519
201912 1.281 107.766 1.557
202003 1.351 106.563 1.660
202006 1.408 107.498 1.715
202009 1.455 107.635 1.770
202012 1.492 108.296 1.804
202103 1.632 108.360 1.972
202106 1.546 108.928 1.859
202109 1.642 110.338 1.949
202112 2.023 112.486 2.355
202203 2.093 114.825 2.387
202206 2.116 118.384 2.341
202209 2.243 122.296 2.402
202212 2.257 126.365 2.339
202303 2.281 127.042 2.351
202306 4.016 129.407 4.064
202309 3.898 130.224 3.920
202312 4.086 130.958 4.086
202403 4.295 130.958 4.295

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotage AB  (STU:PQX1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biotage AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biotage AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (STU:PQX1) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (STU:PQX1) Headlines

No Headlines